Extraordinary Innovations and Emerging Trends in
Transplantation and Oncology from Nebraska Medicine
Printable Schedule-at-a-Glance (Updated: 05/30/2017)
TUESDAY, JULY 11, 2017 — ONCOLOGY AND BMT
Up to 6.25 continuing education credits available. ACPE UAN 0860-0000-17-022-L01-P/0860-0000-17-022-L01-T (.625 CEUs)
Registration and Continental Breakfast
Welcome and Opening Remarks, Theresa Franco, MSN, RN, Vice President, Cancer Center Clinical Operations, Nebraska Medicine and Heidi Leenay, Vice President, OptumHealth Education
The Changes and Advances in Prostate Cancer, Charles Enke, MD; Jon Morton, MD, FACS; Neil Hansen, MD; and Terri Blase, MS, LCGC
The lens through which cancer is being diagnosed, classified and treated is evolving rapidly. Using developments in the diagnosis and treatment of prostate cancer as an example, this session will highlight advances in cancer detection and treatment. New technology such as MR/Ultrasound Fusion biopsy will be highlighted as well as the clinical impact of identifying hereditary gene mutations.
Break — Exhibits Open
Survivorship: The Next Phase of Care, Rachael Schmidt, MSN, APRN
With the seminal report from the Institute of Medicine, “From Cancer Patient to Cancer Survivor: Lost in Transition” in 2006, care of the cancer survivor has become a national priority and has led to the development of multiple models of survivorship. Rachel Schmidt, the nurse practitioner at Nebraska Medicine, who has developed the Survivorship Clinic and care plan at the Fred & Pamela Buffett Cancer Center, will discuss the various models and the steps she used in creating a survivorship program. Her talk will highlight some of the clinical challenges she faces in her patient population. She will also discuss areas for future research in cancer survivorship.
Transplantation for Children with Sickle-cell Disease: Current State and Future Direction, Sachit Patel, MD; Rebecca Swanson, MSN, APRN, CPNP; and Amy Brant, BSN, RN
Members of a pediatric stem cell transplant program will conduct a panel discussion on stem cell transplant for children with sickle-cell disease. Team members will discuss the disease’s manifestations and patient characteristics that make stem cell transplant an option for these afflicted children. The discussion will provide a historical perspective of transplant in this patient population, as well as current transplantation strategies. Members will also offer insight into program-specific approaches to this patient population — before, during and after stem cell transplant.
Lunch (provided) — Exhibits Open
Thyroid Cancer: From Diagnosis to Initial Treatment, Whitney Goldner, MD; Apar Ganti, MD; W. Ken Zhen, MD; and Abbey Fingeret, MD
This year, an estimated 64,300 adults in the United States will be diagnosed with thyroid cancer. It is the most rapidly increasing cancer diagnosis in the U.S. There have been significant advances in the early detection and even more evolution in approaches to the management of the disease. Expert treatment of thyroid cancer is critical to optimal outcomes. A multidisciplinary team approach is the most effective way to address the important decisions surrounding the diagnosis and treatment of thyroid cancer. This presentation will highlight the benefits of such a team for comprehensive care of every patient with a thyroid cancer diagnosis.
Break — Exhibits Open
Autologous Stem Cell Transplantation in Multiple Myeloma (MM): Incorporation of Novel Therapies, Sarah Holstein, MD, PhD
Multiple Myeloma is the second-most-common hematologic malignancy with a wide range of initial presentations. Autologous stem cell transplantation has an important role in the treatment of MM. Treatment options for MM have expanded significantly in the past decade, with novel therapies and treatment strategies being investigated. In this session, Dr. Holstein will review the pathophysiology/epidemiology of myeloma and discuss treatment therapies that have evolved as we have learned more about the disease. She will discuss the role of autologous stem cell transplant and the incorporation of novel drugs and cellular- or vaccine-based strategies in the peritransplant setting.
Improving the Patient Experience: Addressing What Matters Most, Heidi Tonne, BSN, RN, OCN©; Sue Wardian Hartung, RN, MSN, OCN; and Ellie Stull, MSN, RN, OCN
What started as a project to improve our patient satisfaction scores has evolved into an ever-expanding and ongoing journey to improve the overall patient experience. This session will review multiple initiatives that can be undertaken in both the in-patient and outpatient areas to address and improve the patient’s and his/her family’s overall experience while receiving treatment. Engaging patients and families in the discussion and decisions regarding treatment has made these efforts very patient/family centered. One example of an engagement initiative is in the Cancer Care Service’s Patient Family Advisory Council and their impact on the design of the cancer center and some of its programs.
WEDNESDAY, JULY 12, 2017 — SOLID ORGAN TRANSPLANT
Up to 6.25 continuing education credits available. ACPE UAN 0860-0000-17-023-L01-P/0860-0000-17-023-L01-T (.625 CEUs)
Registration and Continental Breakfast — Exhibits Open
Opening Remarks, Alan Langnas, DO, Chief of the Section of Transplantation, Department of Surgery; Lisa Runco, Executive Director of Cardiology and Digestive Diseases and Kidney, Nebraska Medicine; and Heidi Leenay, Vice President, OptumHealth Education
Living Kidney Donation: Share Your Spare, Arika Hoffman, MD
There are over 120,000 people listed for organ transplant nationwide. Living donation presents an opportunity to help address the critical need for organ transplants. Dr. Hoffman will discuss the importance of living kidney donation, how living donors are evaluated, and what we understand about short- and long-term donor outcomes.
Heart Transplantation and Left Ventricular Assist Devices (LVADs), Timothy Ryan, APRN-NP
Heart transplantation is indicated for those patients with end-stage heart failure for whom other treatments have failed. An LVAD may be used as a bridge to transplantation, but it also is a potential permanent alternative to transplantation. Timothy Ryan will discuss how patients are assessed for heart transplant and explain when heart transplantation is contraindicated. He will discuss patient management while waiting for transplant, including medical management and the option for mechanical circulatory support.
Break — Exhibits Open
The Continuum of Organ Donation: A Panel Discussion, Sue Calabro, RN, BSN, CCTC; Leigh Lindner, RN, BSN, CMSRN; Megan Gregory, BSN, RN; Megan Montrie, BS, HDS-C, CPTC; Amber Saltsgaver, RN, BSN; Karen Townsley, BSN, RN; and Amy Schurke, BSN, RN, CCTC
A robust solid organ transplant program requires a multidisciplinary team to create and provide a seamless and efficient transplant process and program. A panel of speakers will share the many aspects of the transplant process, from referral through candidate evaluation, the actual transplant, and in-patient period and post-transplant management and follow-up.
Building a Wall: Biases, Barriers, and Ethics in Transplantation, Jacob Dahlke, MSB
The ethics of allocating human organs for transplantation is a specific application of ethical norms to social practices. Ethical principles and regulatory requirements often overlap in the field of transplantation. Clinical Ethicist, Jacob Dahlke, will identify the broad ethical principles seen in health care. He will then highlight the ethical considerations unique to transplantation. He will also discuss some barriers, including implicit bias, which can limit a fair and equitable transplant process.
Lunch (provided) — Exhibits Open
Transformation of Intestinal Failure Management: A Comprehensive Experience for Patients and Families, David Mercer, MD, PhD, FRCS(S)
Intestinal failure is a serious complication of select conditions, and its management will often include extensive bowel resection surgery. A multidisciplinary intestinal management clinic can provide patients and their families with the opportunity for an improved quality of life, improved nutrition, and often an alternative to intestinal transplantation. Dr. Mercer will discuss an intestinal rehabilitation and transplant program. His talk will include medical and surgical interventions that have shown positive outcomes for children and adults with intestinal failure.
Break — Exhibits Open
Lung Transplantation: Where We Are Now and What the Future Holds, Aleem Siddique, MD
The short supply of organs continues to be a major limiting factor in all solid organ transplantation. But new technologies and techniques continue to improve outcomes as evidenced by the actuarial survival near 90 percent of lung transplant recipients over the last decade. Dr. Siddique will provide an update on the current state of and share some insights into future directions in lung transplantation.
The Ethics of Transplant: Interactive Case Studies, Jacob Dahlke, MSB
Building on his previous session, Clinical Ethicist, Jacob Dahlke, will guide conference participants in an interactive discussion on the application of ethical principles and challenges in solid organ transplantation. Utilizing case studies, participants will be asked to identify biases that may affect decisions related to the allocation of scarce resources. They will be asked to give their input on how these biases can be identified, addressed and resolved. The session is designed to allow maximum audience participation with ample opportunity to give their opinions and share clinical experiences.
Note: OptumHealth Education and Nebraska Medicine reserve the right to make any necessary changes to this program. Efforts will be made to keep presentations as scheduled. However, unforeseen circumstances may result in the substitution of faculty or content. Last updated: 05/30/2017